Liabilities / Assets
20th percentile
Higher debt load relative to assets than 20% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
20th percentile
Higher debt load relative to assets than 20% of similar nonprofits.
Liabilities / Revenue
50th percentile
Higher debt load relative to revenue than 50% of similar nonprofits.
Net Margin
76th percentile
Higher net margin than 76% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
74th percentile
Faster asset growth than 74% of similar nonprofits.
Revenue Growth
71st percentile
Faster revenue growth than 71% of similar nonprofits.
Assets
Up$94,486,324
Up $10,701,770 (+13%) from 2016
Net Assets
Up$89,968,515
Up $10,597,090 (+13%) from 2016
Liabilities
Up$4,517,809
Up $104,680 (+2.4%) from 2016
Revenue
Up$10,978,866
Up $1,337,999 (+14%) from 2016
Expenses
Down$9,058,019
Down $384,923 (-4.1%) from 2016
Net Income
Up$1,920,847
Up $1,722,922 (+870%) from 2016
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
The primary mission is to conduct medical research in conjunction with hospitals for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for devlopment into drugs or other products for the use and benefit of mankind through the Foundation's supporting entities.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.